Rare Diseases: Patient Recruitment Strategies in Clinical Trials
Over a few years, the rate of drug development in rare diseases is increasing, particularly in those countries where the regulators are offering various incentives for drug development in rare diseases. Over the past five years, one-third of the approved drugs were to treat rare diseases. The huge leap of the pharma industry into the […]
Read More →